Dapagliflozin add-on therapy more cost-effective than sitagliptin https://t.co/WUfRp3QAbX — Marisa Peer (@PeerMarisa) August 27, 2018
Dapagliflozin add-on therapy more cost-effective than sitagliptin https://t.co/WUfRp3QAbX
No comments:
Post a Comment